Chen Y - Search Results

1

A simple prognostic model involving prostate-specific antigen, alkaline phosphatase and albumin for predicting the time required to progress to castration-resistant prostate cancer in patients who received androgen deprivation therapy.

Lv W, Shang H, Pei X, Chen Y, Xie H, He D, Wang X, Li L. Lv W, et al. Among authors: chen y. Int Urol Nephrol. 2017 Jan;49(1):61-67. doi: 10.1007/s11255-016-1456-z. Epub 2016 Nov 11. Int Urol Nephrol. 2017. PMID: 27837416

2

[Comparison of transcription factors repressing epithelial phenotype in two different prostate cancer EMT models and its significance].

Wu KJ, Zeng J, Zhu GD, Zhang D, Xue Y, Chen YL, Wang XY, He DL. Wu KJ, et al. Among authors: chen yl. Zhonghua Nan Ke Xue. 2010 Feb;16(2):137-41. Zhonghua Nan Ke Xue. 2010. PMID: 20369697 Chinese.

3

Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria.

Zeng J, Sun Y, Wu K, Li L, Zhang G, Yang Z, Wang Z, Zhang D, Xue Y, Chen Y, Zhu G, Wang X, He D. Zeng J, et al. Among authors: chen y. Mol Cancer Ther. 2011 Jan;10(1):104-16. doi: 10.1158/1535-7163.MCT-10-0577. Mol Cancer Ther. 2011. PMID: 21220495

4

[Epithelial-mesenchymal transition and human fetal prostate development].

Zhou JC, Zhu GD, Wu KJ, Zeng J, Zhang D, Xue Y, Chen YL, Wang XY, He DL. Zhou JC, et al. Among authors: chen yl. Zhonghua Nan Ke Xue. 2011 Feb;17(2):146-50. Zhonghua Nan Ke Xue. 2011. PMID: 21404713 Chinese.

5

Specific survivin dual fluorescence resonance energy transfer molecular beacons for detection of human bladder cancer cells.

Wang ZQ, Zhao J, Zeng J, Wu KJ, Chen YL, Wang XY, Chang LS, He DL. Wang ZQ, et al. Acta Pharmacol Sin. 2011 Dec;32(12):1522-8. doi: 10.1038/aps.2011.122. Epub 2011 Oct 24. Acta Pharmacol Sin. 2011. PMID: 22019956 Free PMC article.

6

Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction.

Xue Y, Li L, Zhang D, Wu K, Chen Y, Zeng J, Wang X, He D. Xue Y, et al. Among authors: chen y. PLoS One. 2011;6(11):e27748. doi: 10.1371/journal.pone.0027748. Epub 2011 Nov 15. PLoS One. 2011. PMID: 22110753 Free PMC article.

7

Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.

Wu K, Zeng J, Zhou J, Fan J, Chen Y, Wang Z, Zhang T, Wang X, He D. Wu K, et al. Among authors: chen y. Urol Oncol. 2013 Nov;31(8):1751-60. doi: 10.1016/j.urolonc.2012.02.001. Epub 2012 Mar 14. Urol Oncol. 2013. PMID: 22421353

8

Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.

Liang L, Li L, Zeng J, Gao Y, Chen YL, Wang ZQ, Wang XY, Chang LS, He D. Liang L, et al. Among authors: chen yl. Oncol Rep. 2012 Sep;28(3):999-1005. doi: 10.3892/or.2012.1874. Epub 2012 Jun 19. Oncol Rep. 2012. PMID: 22736024

9

PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription.

Wu K, Fan J, Zhang L, Ning Z, Zeng J, Zhou J, Li L, Chen Y, Zhang T, Wang X, Hsieh JT, He D. Wu K, et al. Among authors: chen y. Cell Signal. 2012 Dec;24(12):2273-82. doi: 10.1016/j.cellsig.2012.08.004. Epub 2012 Aug 18. Cell Signal. 2012. PMID: 22906492

10

Twist confers chemoresistance to anthracyclines in bladder cancer through upregulating P-glycoprotein.

Chen Y, Li L, Zeng J, Wu K, Zhou J, Guo P, Zhang D, Xue Y, Liang L, Wang X, Chang LS, He D. Chen Y, et al. Chemotherapy. 2012;58(4):264-72. doi: 10.1159/000341860. Epub 2012 Sep 12. Chemotherapy. 2012. PMID: 22986993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179,799 results

Search Page

Filters